Clin2
NCT05137665Possibly a fitRecruiting

Study tracks ALS and health markers over time at home

Amyotrophic Lateral SclerosisMovement DisordersDegenerative DisorderMotor Neuron Disease

Part of Brain & nervous system, Hormones & metabolism clinical trials.

This study follows people with ALS and healthy volunteers to measure how specific body fluids, symptoms, and at-home tracking change over time. It may help researchers find early signs of disease changes and better ways to measure treatment effects.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,000 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You must be 18 years old or older
  • If you have ALS: you must have an ALS diagnosis based on standard clinical criteria
  • If you have ALS: your breathing test (FVC) should be at least 30%, or the study doctor may allow it
  • You must be able to understand the study and give informed consent
  • You must be able to follow study visits, tests, and at-home check-ins
  • If you are healthy (no ALS): you should have no past neurological diseases and no known ALS-related gene mutation

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06578195Recruiting
Assess all ALS study

This study follows people with ALS and healthy volunteers over time to understand the disease better. You can join from home using a smartphone or computer.

Birmingham, Alabama
NCT04882904Recruiting
Tracking movement in people with ALS and healthy volunteers

This study continuously measures activity and movement in people with ALS and in control participants. It aims to better understand how muscle disease changes day-to-day function, which may help improve future monitoring or care.

Liège, Liège
NCT05204017Recruiting
Study platform to better understand and treat ALS

This study uses a comprehensive analysis platform to better understand ALS (and related conditions) and help find ways to “remedy and eliminate” it. If you have ALS or are a healthy control who can safely complete questionnaires and possibly an MRI, you may be able to contribute data that researchers use to improve care.

Edmonton, Alberta
NCT00317616Recruiting
Study for people at high risk of ALS before symptoms start

This study follows healthy people from families with a known ALS-causing gene mutation to look for early body or brain changes before symptoms begin. It may help researchers find ways to predict ALS risk earlier so future treatments can start sooner.

Miami, Florida
NCT02869048Recruiting
Study blood and immune signals in ALS and healthy controls

This trial studies the “innate immune system” (your body’s first-line immune response) in people with ALS and in comparison groups. It may help researchers understand what drives ALS and how immune changes could relate to symptoms.

Aarhus
NCT05474235Recruiting
ALS and motor neuron disease studies for patients, family, and controls

This study looks at people with amyotrophic lateral sclerosis (ALS), people who might have ALS, and also people related to someone with ALS. It may help researchers better understand ALS and related “motor neuron” conditions, and it involves participation that may include blood tests.

Jacksonville, Florida

Hear when a new Amyotrophic Lateral Sclerosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.